An experimental treatment that uses small therapeutic agents to cross the blood-brain barrier by turning off P-glycoprotein, which prevents drugs from reaching the brain, is being seen as a possible way of treating a number of central nervous system diseases including brain cancer and neurological complications of HIV. The findings appeared online Sept. 4 in the iProceedings of the National Academy of Sciences/i, and is the result of a study from scientists ...Monday, 10 September 2012
Experimental Method of Delivering Drugs to the Brain Shows Potential in Treating Brain Cancer
An experimental treatment that uses small therapeutic agents to cross the blood-brain barrier by turning off P-glycoprotein, which prevents drugs from reaching the brain, is being seen as a possible way of treating a number of central nervous system diseases including brain cancer and neurological complications of HIV. The findings appeared online Sept. 4 in the iProceedings of the National Academy of Sciences/i, and is the result of a study from scientists ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment